Delwedd Flaen

Novel piperazine-chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation

New piperazine-chalcone hybrids and related pyrazoline derivatives have been designed and synthesised as potential vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors. The National Cancer Institute (NCI) has selected six compounds to evaluate their antiproliferative activity in vitro...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Marwa F. Ahmed (Awdur), Eman Y. Santali (Awdur), Radwan El-Haggar (Awdur)
Fformat:	Llyfr
Cyhoeddwyd:	Taylor & Francis Group, 2021-01-01T00:00:00Z.
Pynciau:	article
Mynediad Ar-lein:	Connect to this object online.
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Virtual screening of anticancer activity of chalcones and pyrazolines as potential EGFR, VEGFR, and cytochrome P450 inhibitors
gan: Hesti Lina Wiraswati, et al.
Cyhoeddwyd: (2023)

Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations
gan: Hesham Haffez, et al.
Cyhoeddwyd: (2023)

The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline-Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents
gan: Yousaf Khan, et al.
Cyhoeddwyd: (2023)

Design, Synthesis, Antimicrobial Properties, and Molecular Docking of Novel Furan-Derived Chalcones and Their 3,5-Diaryl-∆<sup>2</sup>-pyrazoline Derivatives
gan: Inas S. Mahdi, et al.
Cyhoeddwyd: (2023)

Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors
gan: Md. Jahangir Alam, et al.
Cyhoeddwyd: (2022)

A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents
gan: Kashif Haider, et al.
Cyhoeddwyd: (2022)

Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities
gan: Yahya Yaseen, et al.
Cyhoeddwyd: (2022)

Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity
gan: Mourad AAE, et al.
Cyhoeddwyd: (2020)

Docking, synthesis, and anticancer assessment of novel quinoline-amidrazone hybrids
gan: Ahmad H. Abdullah, et al.
Cyhoeddwyd: (2024)

Molecular docking and dynamics analysis of halogenated imidazole chalcone as anticancer compounds
gan: Winarto Haryadi, et al.
Cyhoeddwyd: (2023)

New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
gan: Mohammad M. Al-Sanea, et al.
Cyhoeddwyd: (2023)

Design, synthesis and evaluation of new methyl piperazine derivatives as anticancer agents
gan: Mahaveer Singh, et al.
Cyhoeddwyd: (2024)

Synthesis of chalcone incorporated quinazoline derivatives as anticancer agents
gan: Sapavat Madhavi, et al.
Cyhoeddwyd: (2017)

Synthesis of Some New Pyrazolines
gan: A.J. AL-Hamdany, et al.
Cyhoeddwyd: (2006)

Anticonvulsant evaluation of 2-pyrazolines carrying naphthyl moiety: An insight into synthesis and molecular docking study
gan: Birjees Nusrat, et al.

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers
gan: Mohammed M. Alanazi, et al.
Cyhoeddwyd: (2021)

Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
gan: Hamada Hashem, et al.
Cyhoeddwyd: (2024)

2-Thiopyrimidine/chalcone hybrids: design, synthesis, ADMET prediction, and anticancer evaluation as STAT3/STAT5a inhibitors
gan: Phoebe F. Lamie, et al.
Cyhoeddwyd: (2020)

Novel alloxazine analogues: design, synthesis, and antitumour efficacy enhanced by kinase screening, molecular docking, and ADME studies
gan: Doaa Samaha, et al.
Cyhoeddwyd: (2024)

Synthesis of pyrazole and pyrazoline derivatives of β-ionone: Exploring anti-inflammatory potential, cytotoxicity, and molecular docking insights
gan: Monika Sihag, et al.
Cyhoeddwyd: (2024)

Comparison of various synthesis methods and synthesis parameters of pyrazoline derivates
gan: Meilinda Setya Praceka, et al.
Cyhoeddwyd: (2021)

Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues
gan: Alam MJ, et al.
Cyhoeddwyd: (2016)

Design, synthesis and molecular docking study of coumarin pyrazoline derivatives against MCF-7 breast cancer cell line
gan: Wafaa Yusuf Khalaf, et al.
Cyhoeddwyd: (2023)

Identification of New <i>N</i>-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
gan: Ashraf K. El-Damasy, et al.
Cyhoeddwyd: (2023)

Synthesis of New Pyrazolines Derivatives from Coumarine Compounds
gan: W. Gh-Bedewy, et al.
Cyhoeddwyd: (1999)

Novel phthalimide based analogues: design, synthesis, biological evaluation, and molecular docking studies
gan: Ismail M. M. Othman, et al.
Cyhoeddwyd: (2019)

Disubstituted piperazine analogues of trifluoromethylphenylpiperazine and methylenedioxybenzylpiperazine: analytical differentiation and serotonin receptor binding studies
gan: Jack DeRuiter, et al.
Cyhoeddwyd: (2018)

Design, Synthesis and molecular docking study of hybrids of quinazolin-4(3H)-one as anticancer agents
gan: Sukanya Nara, et al.

Design and synthesis of novel oridonin analogues as potent anticancer agents
gan: Qing-Kun Shen, et al.
Cyhoeddwyd: (2018)

Piperazine tethered heterocyclic hybrids: Synthesis, characterization, and in vitro studies from potent proteinase inhibitors to antiproliferative activity
gan: Lairikyengbam Deepti Roy, et al.
Cyhoeddwyd: (2024)

Quinoline based furanones and their nitrogen analogues: Docking, synthesis and biological evaluation
gan: Sukhbir Lal Khokra, et al.
Cyhoeddwyd: (2016)

Sevanol and Its Analogues: Chemical Synthesis, Biological Effects and Molecular Docking
gan: Olga A. Belozerova, et al.
Cyhoeddwyd: (2020)

Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents
gan: Jiabing Wang, et al.
Cyhoeddwyd: (2019)

Synthesis, characterization, preliminary molecular docking, pharmacological activity, and ADME studies of some new pyrazoline derivatives as anti-breast cancer agents
gan: Hayder R. Fadhil, et al.
Cyhoeddwyd: (2024)

Pass and Swiss ADME collaborated in silico docking approach to the synthesis of certain pyrazoline spacer compounds for dihydrofolate reductase inhibition and antimalarial activity
gan: Krishnakumar Lohidakshan, et al.
Cyhoeddwyd: (2018)

Synthesis, anticancer, apoptosis-inducing activities and EGFR and VEGFR2 assay mechanistic studies of 5,5-diphenylimidazolidine-2,4-dione derivatives: Molecular docking studies
gan: Hamad M. Alkahtani, et al.
Cyhoeddwyd: (2019)

Synthesis and antimicrobial activity of 2-chloroquinoline incorporated pyrazoline derivatives
gan: Sandhya Bawa, et al.
Cyhoeddwyd: (2009)

Synthesis and Antimicrobial activity of 2-Chloroquinoline Incorporated Pyrazoline Derivatives.
gan: Bibhu P Panda, et al.
Cyhoeddwyd: (2009)

Novel Coumarin-Nucleobase Hybrids with Potential Anticancer Activity: Synthesis, In Vitro Cell-Based Evaluation, and Molecular Docking
gan: Maiara Correa de Moraes, et al.
Cyhoeddwyd: (2024)

Natural product-inspired synthesis of coumarin-chalcone hybrids as potential anti-breast cancer agents
gan: Nabil A. Alhakamy, et al.
Cyhoeddwyd: (2023)